305 related articles for article (PubMed ID: 30703437)
1. Neuronal overexpression of Alzheimer's disease and Down's syndrome associated DYRK1A/minibrain gene alters motor decline, neurodegeneration and synaptic plasticity in Drosophila.
Lowe SA; Usowicz MM; Hodge JJL
Neurobiol Dis; 2019 May; 125():107-114. PubMed ID: 30703437
[TBL] [Abstract][Full Text] [Related]
2. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
3. A third copy of the Down syndrome cell adhesion molecule (Dscam) causes synaptic and locomotor dysfunction in Drosophila.
Lowe SA; Hodge JJL; Usowicz MM
Neurobiol Dis; 2018 Feb; 110():93-101. PubMed ID: 29196216
[TBL] [Abstract][Full Text] [Related]
4. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X
Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628
[TBL] [Abstract][Full Text] [Related]
5. DYRK1A: a potential drug target for multiple Down syndrome neuropathologies.
Becker W; Soppa U; Tejedor FJ
CNS Neurol Disord Drug Targets; 2014 Feb; 13(1):26-33. PubMed ID: 24152332
[TBL] [Abstract][Full Text] [Related]
6. Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome.
Wegiel J; Kaczmarski W; Barua M; Kuchna I; Nowicki K; Wang KC; Wegiel J; Yang SM; Frackowiak J; Mazur-Kolecka B; Silverman WP; Reisberg B; Monteiro I; de Leon M; Wisniewski T; Dalton A; Lai F; Hwang YW; Adayev T; Liu F; Iqbal K; Iqbal IG; Gong CX
J Neuropathol Exp Neurol; 2011 Jan; 70(1):36-50. PubMed ID: 21157379
[TBL] [Abstract][Full Text] [Related]
7. The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.
Wegiel J; Dowjat K; Kaczmarski W; Kuchna I; Nowicki K; Frackowiak J; Mazur Kolecka B; Wegiel J; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Gong CX; Liu F; Adayev T; Chen-Hwang MC; Hwang YW
Acta Neuropathol; 2008 Oct; 116(4):391-407. PubMed ID: 18696092
[TBL] [Abstract][Full Text] [Related]
8. Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a.
Thomazeau A; Lassalle O; Iafrati J; Souchet B; Guedj F; Janel N; Chavis P; Delabar J; Manzoni OJ
J Neurosci; 2014 Jan; 34(4):1138-47. PubMed ID: 24453307
[TBL] [Abstract][Full Text] [Related]
9. Cell type- and brain structure-specific patterns of distribution of minibrain kinase in human brain.
Wegiel J; Kuchna I; Nowicki K; Frackowiak J; Dowjat K; Silverman WP; Reisberg B; DeLeon M; Wisniewski T; Adayev T; Chen-Hwang MC; Hwang YW
Brain Res; 2004 Jun; 1010(1-2):69-80. PubMed ID: 15126119
[TBL] [Abstract][Full Text] [Related]
10. Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention.
Head E; Lott IT; Patterson D; Doran E; Haier RJ
J Alzheimers Dis; 2007 Mar; 11(1):61-76. PubMed ID: 17361036
[TBL] [Abstract][Full Text] [Related]
11. DYRK1a Inhibitor Mediated Rescue of
Zhu B; Parsons T; Stensen W; Mjøen Svendsen JS; Fugelli A; Hodge JJL
Front Pharmacol; 2022; 13():881385. PubMed ID: 35928283
[TBL] [Abstract][Full Text] [Related]
12. DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity.
Zhu B; Parsons T; Foley C; Shaw Y; Dunckley T; Hulme C; Hodge JJL
Sci Rep; 2022 Sep; 12(1):15847. PubMed ID: 36151233
[TBL] [Abstract][Full Text] [Related]
13. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
[TBL] [Abstract][Full Text] [Related]
14. Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome.
Wegiel J; Flory M; Kuchna I; Nowicki K; Wegiel J; Ma SY; Zhong N; Bobrowicz TW; de Leon M; Lai F; Silverman WP; Wisniewski T
Acta Neuropathol Commun; 2022 Jan; 10(1):2. PubMed ID: 34983655
[TBL] [Abstract][Full Text] [Related]
15. The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development.
Hämmerle B; Elizalde C; Tejedor FJ
Eur J Neurosci; 2008 Mar; 27(5):1061-74. PubMed ID: 18364031
[TBL] [Abstract][Full Text] [Related]
16. Activity-dependent facilitation of Synaptojanin and synaptic vesicle recycling by the Minibrain kinase.
Chen CK; Bregere C; Paluch J; Lu JF; Dickman DK; Chang KT
Nat Commun; 2014 Jun; 5():4246. PubMed ID: 24977345
[TBL] [Abstract][Full Text] [Related]
17. Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation.
Lee YH; Im E; Hyun M; Park J; Chung KC
J Biol Chem; 2021; 296():100245. PubMed ID: 33380426
[TBL] [Abstract][Full Text] [Related]
18. Mnb/Dyrk1A orchestrates a transcriptional network at the transition from self-renewing neurogenic progenitors to postmitotic neuronal precursors.
Shaikh MN; Tejedor FJ
J Neurogenet; 2018 Mar; 32(1):37-50. PubMed ID: 29495936
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of β-Tubulin by the Down Syndrome Kinase, Minibrain/DYRK1a, Regulates Microtubule Dynamics and Dendrite Morphogenesis.
Ori-McKenney KM; McKenney RJ; Huang HH; Li T; Meltzer S; Jan LY; Vale RD; Wiita AP; Jan YN
Neuron; 2016 May; 90(3):551-63. PubMed ID: 27112495
[TBL] [Abstract][Full Text] [Related]
20. [Minibrain/DYRK1A gene: candidate gene for mental retardation in Down's syndrome?].
Kentrup H; Joost HG; Heimann G; Becker W
Klin Padiatr; 2000; 212(2):60-3. PubMed ID: 10812554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
